Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cougar Biotechnology, Inc.
Cougar Biotechnology Announces Dismissal of Class Action Complaint Seeking to Enjoin Tender Offer and Termination of Hart-Scott-Rodino Waiting Period
July 11th, 2009
Cougar Biotechnology, Inc. (NASDAQ: CGRB) announced the voluntary dismissal by the plaintiff of a class action complaint filed on May 28, 2009 in the Superior Court of the State of California, Los Angeles County. The complaint, captioned Puzanov v. Cougar Biotechnology, Inc., et al., Case No. BC 414586, sought to enjoin the tender offer commenced by Kite Merger Sub, Inc., a wholly owned subsidiary of Johnson & Johnson (NYSE: JNJ), for all of the outstanding shares of Cougar Biotechnology's common stock at a price of $43.00 per share. Cougar will pay no settlement or attorneys' fees or other expenses of the plaintiff in connection with dismissal of the complaint. Cougar...
Source: Law & Health Weekly (2009-07-11)
|
